Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease.
about
Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.Directing the immune response to carbohydrate antigens.Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide.Solution structure of R(2)Sn(IV)-beta-N-acetyl-neuraminate (R = Me, Bu) complexes in D(2)O and DMSO-d(6): experimental NMR and DFT computational study.A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceUse of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infectionsCharacterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypesActivity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniaeAnti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group BSequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococciTowards an improved serogroup B Neisseria meningitidis vaccine.The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.Controlling serogroup B invasive meningococcal disease: the Canadian perspective.Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses.
P2860
Q30663299-4A8E5F4B-A53F-436E-A846-163E099C14B9Q30672149-6747E532-36D4-49E2-9C1D-973DE611EB0CQ30823942-0D9664D3-1C55-4F0A-8FD5-898AD5896DD6Q31106973-9D7B1E15-88E2-4823-99BA-B99B4A3A5700Q31137207-11D4752B-B21D-4D27-9E85-83972CF80565Q31137212-2BA62556-865F-4E4F-8644-3E35850BB73EQ33434271-04BA288C-DAC7-424D-BE3F-B62B4BAAE34CQ33553979-EECCADDB-7191-4035-B2A0-6E718DA5F13EQ33592253-D7E62A1D-BEE6-4693-814D-9E40E0C69105Q34033132-4AD3854E-C413-440B-B100-0771B2D6C38AQ34076321-BA867CA7-23FD-4298-8846-A708A6629D9FQ34185172-815655D9-FBE5-4D71-94B6-466F8C3AF81DQ36227917-613C5D97-E6A0-478C-924D-464C3BDFFE30Q36327065-1A176134-30FF-45A0-BA64-0639E78217D9Q36646787-072B6FB7-D9AA-418D-A71E-A9D21E268B7EQ37215825-A371C264-5D9A-4CA8-BD91-87239093FABEQ38105338-133C82B6-A229-4E70-B844-53429EFA9F8BQ38290712-F23ACB92-75D9-4985-95A4-1ED1D22FA960
P2860
Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@ast
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@en
type
label
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@ast
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@en
prefLabel
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@ast
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@en
P2093
P1476
Molecular mimetics of polysacc ...... ingitidis serogroup B disease.
@en
P2093
P304
P356
10.1111/J.1574-695X.1999.TB01392.X
P577
1999-12-01T00:00:00Z